<p>We studied the role of microRNA-802 (miR-802) in regulating the sensitivity of non-small cell lung cancer and colorectal cancer cells to the cytotoxic activity of macrophages. Previously, we demonstrated that cells resistant to macrophage-mediated effects are characterized by reduced miR-802 expression. In this study, tumor cell lines expressing miR-802 were generated, and their resistance to macrophages and proliferative activity were assessed. It was found that miR-802 expression decreases cell resistance to macrophage cytotoxicity and slows their proliferation, suggesting its potential role as a tumor suppressor. However, in cells already exhibiting a resistant phenotype, miR-802 expression is suppressed, likely through activation of epigenetic or post-transcriptional mechanisms. These results are consistent with previously published data on the dual role of miR-802 in different tumor types. Thus, miR-802 may play an important role in the development of tumor cell resistance to the immune response and could be of interest as a potential therapeutic target in immunotherapeutic approaches.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

The Influence of miR-802 on the Resistance of Non-Small Cell Lung Cancer and Colorectal Cancer Cells to Macrophage Cytotoxic Activity

  • O. V. Kovaleva,
  • V. V. Sinyov,
  • M. A. Rashidova,
  • O. S. Malashenko,
  • N. E. Kushlinskii,
  • A. N. Gratchev

摘要

We studied the role of microRNA-802 (miR-802) in regulating the sensitivity of non-small cell lung cancer and colorectal cancer cells to the cytotoxic activity of macrophages. Previously, we demonstrated that cells resistant to macrophage-mediated effects are characterized by reduced miR-802 expression. In this study, tumor cell lines expressing miR-802 were generated, and their resistance to macrophages and proliferative activity were assessed. It was found that miR-802 expression decreases cell resistance to macrophage cytotoxicity and slows their proliferation, suggesting its potential role as a tumor suppressor. However, in cells already exhibiting a resistant phenotype, miR-802 expression is suppressed, likely through activation of epigenetic or post-transcriptional mechanisms. These results are consistent with previously published data on the dual role of miR-802 in different tumor types. Thus, miR-802 may play an important role in the development of tumor cell resistance to the immune response and could be of interest as a potential therapeutic target in immunotherapeutic approaches.